Condition

Refractory Lymphoma clinical trials and research

• 9Clinical trials
• 4Countries

Newest Refractory Lymphoma clinical trials

All recruiting trials (9)

• BAFF CAR-T (LMY-920) therapy for relapsed or refractory CLL/SLL

  This trial tests BAFF CAR-T cell therapy (LMY-920) with prior obinutuzumab in adults whose CLL or SLL has relapsed or not responded to prior treatments including BTK and BCL2 inhibitors.

  Recruiting Phase 1 Case Comprehensive Cancer Center · Cleveland, Ohio · NCT06916767

• GB5005 CART-cell injection for treating relapsed B-cell non-Hodgkin lymphoma

  This study is testing a new CAR-T cell treatment called GB5005 to see if it can help people with relapsed B-cell non-Hodgkin lymphoma feel better and manage side effects.

  Recruiting Phase 1 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06875063

• Treatment for patients with relapsed follicular lymphoma using Axicabtagene Ciloleucel Injection

  This study is testing a new treatment called Axicabtagene Ciloleucel Injection to see if it can help Chinese patients with relapsed follicular lymphoma who have already tried other therapies.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06826118

• Evaluating HDM2005 for patients with relapsed B-cell lymphoma and advanced solid tumors

  This study is testing a new drug called HDM2005 to see if it can help people with relapsed B-cell lymphoma and advanced solid tumors feel better.

  Recruiting at 4 sites Phase 1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Zhengzhou, Henan and 7 other locations · NCT06615193

• Combination treatment for relapsed or refractory follicular lymphoma

  This study is testing a new combination of three medications to see if it can help people with relapsed or refractory follicular lymphoma feel better.

  Recruiting at 3 sites Phase 2 Dana-Farber Cancer Institute · Boston, Massachusetts and 2 other locations · NCT06563596

• Improving diagnosis of hematological diseases using advanced sequencing techniques

  This study is testing new genetic sequencing methods to help doctors better diagnose blood disorders in patients who currently have unclear or unusual symptoms.

  Recruiting Munich Leukemia Laboratory · Munich · NCT05046444

• CBL0137 treatment for relapsed or refractory solid tumors and CNS tumors

  This study is testing a new treatment called CBL0137 to see if it can help children and young adults with tough-to-treat solid tumors and brain tumors feel better.

  Recruiting at 33 sites Phase 1/2 Children's Oncology Group · Birmingham, Alabama and 34 other locations · NCT04870944

• Combination treatment for mantle cell lymphoma

  This study is testing a combination of three drugs to see if they can help people with mantle cell lymphoma that has come back or hasn't been treated yet.

  Recruiting at 3 sites Phase 1/2 Dana-Farber Cancer Institute · Chicago, Illinois and 2 other locations · NCT04855695

• Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions

  This study is testing if adding vitamin C to standard chemotherapy can help people with relapsed or hard-to-treat lymphomas and related blood conditions feel better.

  Recruiting Phase 2 Mayo Clinic · Mankato, Minnesota and 3 other locations · NCT03418038

Related topics

Quick answers

How many Refractory Lymphoma clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (5 trials), China (3 trials), Australia (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 3, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →